| Table 1. Baseline characteristics for patients | |||
| Parameter | Group 1 (Cyclogest) n = 23 |
Group 2 (Variopeptyl) n = 21 |
|
|---|---|---|---|
| Female age (Y), mean (SD) | 31.78± 5.3 | 29.85± 4.34 | 0.20 |
| BMI (kg/m2), mean (SD) | 24.22± 2.29 | 23.9± 2.27 | 0.65 |
| AMH (ng/ml), median (IQR) | 2.4 (1.4-4.5) | 3.3 (1.6-4.7) | 0.55 |
| Baseline FSH (IU/L), mean (SD) | 3.07± 1.03 | 3.34± 0.77 | 0.33 |
| Baseline LH (IU/L), mean (SD) | 4.77± 1.89 | 3.68± 2.14 | 0.08 |
| Baseline Estrogen (pg/mL), median (IQR) | 43 (35-54.9) | 44 (36-55) | 0.73 |
| Baseline Progesterone (ng/mL), median (IQR) | 0.6 (0.49-0.7) | 0.78 (0.57-0.9) | 0.06 |
| Infertility duration (Y), median (IQR) | 3 (2-4) | 3 (2-4) | 0.85 |
| Male factor infertility, n (%) | 7 (30.4) | 4 (19.0) | 0.38 |